Inflammatory bowel disease among radiographic axial spondyloarthritis’ patients: Frequency and diagnostic value of fecal calprotectin

Key Points

• Fecal calprotectin levels correlate with the presence of inflammatory bowel disease, indicating its diagnostic utility.
• Patients with axial spondyloarthritis showed a notable frequency of inflammatory bowel disease diagnosed through fecal calprotectin tests.
• Assessment involved comparing fecal calprotectin results against conventional diagnostic criteria for inflammatory bowel disease.
• Findings imply that fecal calprotectin can enhance early diagnosis of gastrointestinal complications in axial spondyloarthritis.